Texas

Resilience System


You are here

J&J Covid-19 vaccine lasts at least 8 months, protects against Delta variant --new studies

Primary tabs

(CNN) The Johnson & Johnson coronavirus vaccine provides immunity that lasts at least eight months, and it appears to provide adequate protection against the worrying Delta variant, the company said in a statement Thursday night.

"Current data for the eight months studied so far show that the single-shot Johnson & Johnson COVID-19 vaccine generates a strong neutralizing antibody response that does not wane; rather, we observe an improvement over time," Dr. Mathai Mammen, head of research and development at J&J's Janssen vaccine arm, said in a statement.
 
The company said one dose of the vaccine elicits both a lasting antibody response and generates immune cells called T-cells that last eight months, also.
Dr. Dan Barouch of Beth Israel Deaconess Medical Center and Harvard Medical School and colleagues tested blood taken from 20 volunteers in an early stage, Phase 1/2 trial of the vaccine.
"These data are promising and reassuring," Barouch told CNN. Barouch has submitted his findings to the BioRxiv pre-print server.
    "Data showed that T-cell responses -- including CD8+ T-cells that seek out and destroy infected cells -- persisted over the eight-month timeframe examined," the company said.
     
    These are not real-world efficacy data, but antibody and T-cell response usually indicate protection, Barouch said.
      Pfizer/BioNTech and Moderna have both said their two-dose vaccines are protective for at least six months and researchers at Washington University in St. Louis reported earlier this week that their studies of vaccinated volunteers indicate protection from the vaccines should last much longer than that-- even for years. They did not test the J&J vaccine...
       
      Country / Region Tags: 
      Problem, Solution, SitRep, or ?: 
      Groups this Group Post belongs to: 
      - Private group -
      howdy folks
      Page loaded in 0.407 seconds.